These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1716408)

  • 21. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation by image analysis of a turbidimetric method to study calcium oxalate crystallization.
    Hennequin C; Lalanne V; Estepa L; Drueke T; Daudon M; Lacour B
    Clin Nephrol; 1997 Nov; 48(5):292-9. PubMed ID: 9403213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleation, adhesion, and internalization of calcium-containing urinary crystals by renal cells.
    Lieske JC; Deganello S
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S422-9. PubMed ID: 10541277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The inhibitory effects of Takusha on the formation, growth and aggregation of calcium oxalate crystals in vitro].
    Kawamura K; Moriyama M; Nakajima C; Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1993 Aug; 39(8):695-700. PubMed ID: 8379469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium oxalate crystal growth in human urinary stones.
    Kim KM; Johnson FB
    Scan Electron Microsc; 1981; (Pt 3):147-54. PubMed ID: 7330575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on calcium oxalate monohydrate crystallization: influence of inhibitors.
    Grases F; Kroupa M; Costa-Bauzá A
    Urol Res; 1994; 22(1):39-43. PubMed ID: 7521089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of calcium oxalate monohydrate crystallization kinetics in vitro.
    Kok DJ; Papapoulos SE; Blomen LJ; Bijvoet OL
    Kidney Int; 1988 Sep; 34(3):346-50. PubMed ID: 2459439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].
    Miyazawa K; Suzuki K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):861-9. PubMed ID: 2477580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mimicking the growth of a pathologic biomineral: shape development and structures of calcium oxalate dihydrate in the presence of polyacrylic acid.
    Thomas A; Rosseeva E; Hochrein O; Carrillo-Cabrera W; Simon P; Duchstein P; Zahn D; Kniep R
    Chemistry; 2012 Mar; 18(13):4000-9. PubMed ID: 22354632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new approach to studying inhibitors of calcium oxalate crystal growth.
    Hennequin C; Lalanne V; Daudon M; Lacour B; Drueke T
    Urol Res; 1993 Mar; 21(2):101-8. PubMed ID: 8389069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Clin Sci (Lond); 1985 Mar; 68(3):369-71. PubMed ID: 2578913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel basic protein from human kidney which inhibits calcium oxalate crystal growth.
    Selvam R; Kalaiselvi P
    BJU Int; 2000 Jul; 86(1):7-13. PubMed ID: 10886075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of magnesium in calcium oxalate urolithiasis.
    Kohri K; Garside J; Blacklock NJ
    Br J Urol; 1988 Feb; 61(2):107-15. PubMed ID: 3349276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scanning electron microscopic study of the effect of citrate and pyrophosphate on calcium oxalate crystal morphology.
    Shirane Y; Kagawa S
    J Urol; 1993 Dec; 150(6):1980-3. PubMed ID: 8230549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?
    Jones M; Monga M
    J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.